Evidence map›Paper›PMID 39375911›Full record

ArticleThe American journal of case reports2024

A Rare Complication of Cannabinoid Hyperemesis Syndrome.

Hallie E Knight, Abhinav Singla, Michael Smerina, Melissa P Cortes, Tatjana Gavrancic, Deborah A Baumgarten, Adrian G Dumitrascu, Ricardo J Pagan, Aleksandra Murawska Baptista

Abstract readCase Reports
In one paragraph

Article in The American journal of case reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Hallie E KnightClinical Research Internship Study Program, Mayo Clinic, Jacksonville, FL, USA.
Abhinav SinglaDivision of General Internal Medicine, Mayo Clinic, Rochester, MN, USA.
Michael SmerinaDivision of Hospital Internal Medicine, Mayo Clinic, Jacksonville, FL, USA.
Melissa P CortesDivision of Hospital Internal Medicine, Mayo Clinic, Jacksonville, FL, USA.
Tatjana GavrancicDivision of Hospital Internal Medicine, Mayo Clinic, Jacksonville, FL, USA.
Deborah A BaumgartenDepartment of Radiology, Mayo Clinic, Jacksonville, FL, USA.
Adrian G DumitrascuDivision of Hospital Internal Medicine, Mayo Clinic, Jacksonville, FL, USA.ORCID 0000-0003-1557-9791
Ricardo J PaganDivision of Hospital Internal Medicine, Mayo Clinic, Jacksonville, FL, USA.
Aleksandra Murawska BaptistaDivision of Hospital Internal Medicine, Mayo Clinic, Jacksonville, FL, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND Cognitive errors are common in medical practice and can have serious consequences for patients related to misdiagnosis and delays in diagnosis and treatment. We report a case in which cognitive error substantially influenced a patient's diagnosis and treatment. CASE REPORT This report recounts the case of an adolescent girl with symptoms similar to those of her previous episodes of tetrahydrocannabinol-induced hyperemesis, despite a 21-kg weight loss over 6 months. She sought care at multiple facilities until finally being diagnosed with superior mesenteric artery syndrome. Treatment was conservative with intravenous hydration, nasogastric feeding, and gastric decompression until duodenal compression was relieved. The patient's condition had improved at 7-month follow-up, and she declined surgical consultation. CONCLUSIONS This case report seeks to raise awareness of the effects of cognitive errors in clinical practice. This tendency to prematurely attribute symptoms to a known diagnosis and thereby overlook alternative and potentially more accurate explanations can lead to delays in diagnoses and treatments. Awareness of cognitive error is especially important in the context of the increasing prevalence of legalization of tetrahydrocannabinol/marijuana in several states. Superior mesenteric artery syndrome, although rare, is linked to high morbidity and mortality when the diagnosis is delayed; thus, it is crucial to consider it in the differential diagnosis for a patient with weight loss and abdominal pain. By sharing this case, we hope clinicians and patients can become more aware of this rare consequence of tetrahydrocannabinol use to facilitate more comprehensive patient-centered investigations.

Indexed as

Superior Mesenteric Artery SyndromeVomitingAdolescentCannabinoid Hyperemesis SyndromeCannabinoidsDiagnostic ErrorsFemaleHumansSyndromeCannabinoids

Identifiers

PMID39375911
PMCPMC11470776

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.